Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 14 h ago

ACHIEVE LIFE SCIENCES, INC.: Venrock Healthcare Capital Partners III, L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Venrock Healthcare Capital Partners III, L.P. filed an amended Schedule 13G with the SEC (accession 0001738048-26-000088) updating its beneficial ownership position in Achieve Life Sciences, Inc. The amendment signals a change in the venture firm's reported stake, though the filing summary did not disclose the revised share count or percentage. Schedule 13G amendments are typically filed when a passive investor's ownership crosses the 5% threshold or moves by more than 5% of the class. The update matters because Venrock is a long-standing institutional backer, and shifts in its position can signal changing conviction in Achieve's late-stage cytisinicline smoking-cessation program. Investors will watch for the full filing details to confirm whether Venrock added to or trimmed its holdings.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Venrock Healthcare Capital Partners III, L.P., Achieve Life Sciences, Inc.